These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 19363471)
1. Combined inhibition of PAK7, MAP3K7 and CK2alpha kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts. Giroux V; Iovanna JL; Garcia S; Dagorn JC Cancer Gene Ther; 2009 Sep; 16(9):731-40. PubMed ID: 19363471 [TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326 [TBL] [Abstract][Full Text] [Related]
3. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]. Liu JP; Yuan SZ; Zhang SN Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254 [TBL] [Abstract][Full Text] [Related]
4. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
5. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo. Shi XH; Liang ZY; Ren XY; Liu TH Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011 [TBL] [Abstract][Full Text] [Related]
6. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of siRNA expression plasmid specific to protein kinase CK2alpha on human laryngeal carcinoma xenograft in nude mice]. Wang J; Gong S; Liu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 23(6):267-70. PubMed ID: 19621601 [TBL] [Abstract][Full Text] [Related]
8. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles. Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377 [TBL] [Abstract][Full Text] [Related]
9. Roles of Fyn in pancreatic cancer metastasis. Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749 [TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Li M; Zhang Y; Bharadwaj U; Zhai QJ; Ahern CH; Fisher WE; Brunicardi FC; Logsdon CD; Chen C; Yao Q Clin Cancer Res; 2009 Oct; 15(19):5993-6001. PubMed ID: 19755388 [TBL] [Abstract][Full Text] [Related]
12. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669 [TBL] [Abstract][Full Text] [Related]
13. A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model. Iwaki K; Shibata K; Ohta M; Endo Y; Uchida H; Tominaga M; Okunaga R; Kai S; Kitano S Int J Cancer; 2008 Feb; 122(3):658-63. PubMed ID: 17935125 [TBL] [Abstract][Full Text] [Related]
14. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594 [TBL] [Abstract][Full Text] [Related]
15. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer. Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model. Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760 [TBL] [Abstract][Full Text] [Related]
17. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1. Yang Y; Tao X; Li CB; Wang CM Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739 [TBL] [Abstract][Full Text] [Related]
19. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Heider TR; Lyman S; Schoonhoven R; Behrns KE Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292 [TBL] [Abstract][Full Text] [Related]
20. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells. Hamacher R; Saur D; Fritsch R; Reichert M; Schmid RM; Schneider G Oncol Rep; 2007 Sep; 18(3):695-701. PubMed ID: 17671722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]